Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00846
|
|||||
| Drug Name |
Flutamide
|
|||||
| Synonyms |
1A Brand of Flutamide; 2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide; 4'-Nitro-3'-(trifluoromethyl)isobutyranilide; 4'-Nitro-3'-trifluoromethylisobutyramilide; 4'-Nitro-3'-trifluoromethylisobutyranilide; 4-Nitro-3-(trifluoromethyl)isobutyranilide; Alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide; Alphapharm Brand of Flutamide; Apimid; Apo Flutamide; Apo-Flutamide; ApoFlutamide; Apogepha Brand of Flutamide; Apotex Brand of Flutamide; Azupharma Brand of Flutamide; Cebatrol; Cebatrol, veterinary; Cell pharm Brand of Flutamide; Chephasaar Brand of Flutamide; Chimax; Chiron Brand of Flutamide; Ciclum Brand of Flutamide; Cytamid; Drogenil; Esparma Brand of Flutamide; Essex Brand of Flutamide; Eulexin; Eulexin (TN); Eulexin, Flutamin, Drogenil,Flutamide; Eulexine; F 9397; F0663; Fluken; Flulem; Flumid; Fluta 1A Pharma; Fluta GRY; Fluta cell; Fluta-GRY; Fluta-cell; FlutaGRY; Flutacell; Flutamida; Flutamida [INN-Spanish]; Flutamide (AR inhibitor); Flutamide (JAN/USP/INN); Flutamide USP25; Flutamide [USAN:BAN:INN]; Flutamide(pubertal study); Flutamidum; Flutamidum [INN-Latin]; Flutamin; Flutandrona; Flutaplex; Flutexin; Fugerel; Gry Brand of Flutamide; Ham's F-12 medium; Hexal Brand of Flutamide; InibsaBrand of Flutamide; Ipsen Brand of Flutamide; Juta Brand of Flutamide; Kendrick Brand of Flutamide; Lemery Brand of Flutamide; M-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-(8CI); M-propionotoluidide,alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro; METHOXYCHLOR; NFBA; NK-601; Niftholide; Niftolid; Niftolide; Novo Flutamide; Novo-Flutamide; NovoFlutamide; Novopharm Brand of Flutamide; Odyne; Oncosal; PMS Flutamide; PMS-Flutamide; PUBERTAL FLUTAMIDE STUDY (PUBERTAL STUDIES OF VINCLOZOLIN; Pharmascience Brand of Flutamide; Prasfarma Brand of Flutamide; Prostacur; Prostandril; Prostica; Prostogenat; Q Pharm Brand of Flutamide; Q-Pharm Brand of Flutamide; SCH13521; Sch 13521; Sch-13521; Schering Brand of Flutamide; Schering Plough Brand of Flutamide; Schering-Plough Brand of Flutamide; TAD Brand of Flutamide; Tedec Meiji Brand of Flutamide; Testotard
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Prostate cancer [ICD11: 2C82] | Approved | [1] | |||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C11H11F3N2O3
|
|||||
| Canonical SMILES |
CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
|
|||||
| InChI |
InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)
|
|||||
| InChIKey |
MKXKFYHWDHIYRV-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 13311-84-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 276.21 | Topological Polar Surface Area | 74.9 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
3.3
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:5132
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Flutamide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury. Toxicol Lett. 2003 Apr 30;142(1-2):61-70. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.